CELZ Creative Medical Technology Holdings Inc

$CELZ Actually they are diluting, it looks like he was right after many reverse splits. Unreal. Pump news to dump as usual.

$CELZ Big patent news cell free regenerative medicine platform also $YCBD entering definitive agreement with company similar to CELZ

$CELZ gotta sell these afterhours plays when ur up real fkn quick cause these reverse in one candle

$CELZ The Investor Relations email address published by the company is rejecting messages because the mailbox is full. I also called the telephone number displayed on the company website (480) 399-2822) under “Reach us directly” and received a recording stating that the wireless caller was unavailable. That same telephone number appears in the company's recent SEC filings. I am therefore unable to reach the company through either of the contact methods it provides to shareholders.

$CELZ In an 8-K dated Sept 24, 2026, CELZ bought 4,000,000 BioDefense shares from Creative Acquisition Corp. for $200,000 in cash plus 1,000,000 CELZ shares, leaving CELZ with 80% of BioDefense and CAC with 20%. (sec) In the Schedule 13D dated Oct 1, 2026, Warbington is CELZ's President and CEO and also Chairman and CEO of CAC, which is a holding company. So he sits on both sides of the deal, which is the legitimate governance concern. (sec)

$CELZ $CELZ So in a few words warbington it's a white collar criminal? There's no future with this scam

$CELZ FYI for retail shareholders regarding CEO Timothy Warbington's recent Schedule 13D filing & ownership structure: Timothy Warbington now controls a 13.7% beneficial stake (1,034,904 shares) following the latest BioDefensé, Inc. transaction. While presented as a pipeline consolidation, it is important to understand the related-party mechanics: The Payout: $CELZ handed over $200,000 in cash plus 1,000,000 restricted shares of CELZ common stock to Creative Acquisition Corp. (CAC). The Catch: Warbington 100% owns and controls CAC. The cash and stock went straight to his private entity. • Pattern of Play: This follows similar insider setups, like late 2025's Bionance Management LLC structure (where Warbington's entity gets a 30% cut of investment distributions). While legally disclosed, this is heavy insider self-dealing. The CEO gets guaranteed cash upfront, while retail investors hold the bag on speculative, unproven pipelines. Know what you own!

$CELZ Over 2021–2025, CELZ reported ~$2.41M in compensation for CEO Tim Warbington. I can identify only about $72K of open-market CELZ purchases by him during that period, while CELZ’s split-adjusted share price lost roughly 99% of its value. In 2026 Warbington also received a $100K bonus tied to a warrant-inducement financing that created substantial additional dilution, and now his private company has received $200K + 1M CELZ shares in the BioDefense deal. Long shareholders: does this feel like aligned incentives to you? If you sat on the Compensation Committee, what would you want explained before approving another bonus or award?

$CELZ This is getting frustrating. The account here on STs never responds to questions. I emailed the company’s published IR address today with straightforward questions about the BioDefense ownership/economic structure. The email bounced because the mailbox that ir@creativemedicaltechnology.com forwards to is full I checked my records and discovered the exact same thing happened when I emailed IR on August 10. I’m not suggesting anything sinister. This just strikes me as remarkably sloppy investor communication for a public company. If you publish an IR address, shareholders should actually be able to reach someone through it. I’ve now forwarded the questions to CELZ’s outside IR representatives at The Equity Group.

As clinical programs advance, strategic partnerships can play a role in supporting later-stage development by providing additional resources, expertise and development capabilities. For $CELZ, evaluating potential strategic and partnering opportunities is part of Olastrocel’s stated development priorities as the ADAPT clinical dataset matures. This evaluation is one component of the broader strategy for supporting Olastrocel through its next stages of development.

$CELZ If there's a possibility of BO or a big collaboration before phase 3,,, it will be because of Olastrocel.... Everything else will be cut!! This is the realistic picture of CELZ

ADAPT is our most advanced clinical program, but it represents one part of a broader $CELZ development platform. Our pipeline spans multiple areas of regenerative medicine and immunotherapy, with programs at different stages of development across CELZ’s proprietary cell-based platforms.

$CELZ It took one month on $ARTL was legit just me and two other guys on the board and then boom 100% This is my next banger Celz

$CELZ Let s pump back to $1.2S they will cover or we can pump this in overnight while they can't short//

$CELZ got stopped out but re-entered. Pure gamble guys, don’t put serious money into this. I full ported my gambling portfolio

$CELZ crazy, patent news use to get like 3-10 percent pops then red . Now they get 50-200 percent lol free $$$ every where

$CELZ starting to look a bit undervalued right now. Ultrasome deal soon. Burn grant soon. Adapt data minus opioid arm completed. Rmat/FDA phase 3 chat in a few months

$CELZ FYI According to Creative Medical Technology 2026 (YTD Metrics): His active base contract dictates a $339,720 annual salary, and on July 1, 2026, the board's Compensation Committee authorized an additional $100,000 cash bonus. SEC.gov +2

$CELZ I think Celz holds more patents then ford motor company. How much revenue has been generated from all those patents? Zero

$CELZ I held on to a couple of shares of Celz I bought about 7 years ago on OTC. Just as a reminder that this company is a scam. Always on the edge of a life changing breakthrough that never materializes. By the way after all the RS and delusion over the years my breakeven on the shares I have is over 1000 per share.